Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03356847
Other study ID # IDIL/2017/DM-01
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 29, 2017
Est. completion date July 11, 2018

Study information

Verified date November 2017
Source Centre Hospitalier Universitaire de Nimes
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A good efficacy as well as good rotary stability is expected with the ocular implant.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date July 11, 2018
Est. primary completion date July 11, 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- The patient must have given their free and informed consent and signed the consent form

- The patient must be a member or beneficiary of a health insurance plan

- The patient must be available for 6 months follow-up

- The patient it aged at least 18 years

- Patient requires surgery for cataracts with removal of the opacified natural lens and replacement with the SISA implant, according to standard procedure

- The surgery is elective

- The patient has clear and non-pathological corneas

- The patient needs an implant strength (LIO) between +10D and +30D

- Corneal astigmatism less than or equal to 1.50D in the eye to be operated (or cataract eye

Exclusion Criteria:

- The subject is participating in an interventional study, or is in a period of exclusion determined by a previous study

- The patient is under safeguard of justice or state guardianship

- The subject refuses to sign the consent

- It is impossible to give the subject informed information

- The patient is pregnant or breastfeeding

- The patient has other ocular comorbidities with poor visual acuity prognosis postoperatively

- Previous ocular trauma or surgery

- Dilation of the pupil <7mm with mydriatic drugs

- Implantation with a rhexis that does not cover the optic of the implant by more than 1 cadranel

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Fitting of ocular implant
Removal of natural lens and replacement with a SISA monofocal intraocular implant

Locations

Country Name City State
France CHU Nimes Nîmes

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Nimes

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Rotational stability of SISA monofocal implant following cataracts surgery rotation in degrees measured by Labview software 4 Months
Secondary Rotational stability of SISA monofocal implant following cataracts surgery rotation in degrees measured by Labview software Day 0
Secondary Rotational stability of SISA monofocal implant following cataracts surgery rotation in degrees measured by Labview software Day 7
Secondary Rotational stability of SISA monofocal implant following cataracts surgery rotation in degrees measured by Labview software 1 Month
Secondary Centering of SISA monofocal implant Distance in mm between centers of the coreal and optic ellipses Day 0
Secondary Centering of SISA monofocal implant Distance in mm between centers of the coreal and optic ellipses Day 7
Secondary Centering of SISA monofocal implant Distance in mm between centers of the coreal and optic ellipses Month 1
Secondary Centering of SISA monofocal implant Distance in mm between centers of the coreal and optic ellipses Month 4
Secondary Refractive precision Early Treatment Diabetic Retinopathy Study scale; chart 1 at 4 meters; diopters Day 7
Secondary Refractive precision Early Treatment Diabetic Retinopathy Study scale; chart 1 at 4 meters; diopters; Month 1
Secondary Refractive precision Early Treatment Diabetic Retinopathy Study scale; chart 1 at 4 meters; diopters Month 4
Secondary Visual acuity with and without correction Early Treatment Diabetic Retinopathy Study scale, logMAR Day 7
Secondary Visual acuity with and without correction Early Treatment Diabetic Retinopathy Study scale, logMAR Month 1
Secondary Visual acuity with and without correction Early Treatment Diabetic Retinopathy Study scale, logMAR Month 4
Secondary Perioperative complications Yes/no Day 0
Secondary Postoperative complications Yes/no Day 7
Secondary Occurrence of undesirable events, Presence/absence of each event, including, but not limited to: inflammation, retinal detachment, macular edema, corneal endothelial lesion,corneal edema, implant gets decentred or tilted, Day 0
Secondary Occurrence of undesirable events, Presence/absence of each event, including, but not limited to: inflammation, retinal detachment, macular edema, corneal endothelial lesion,corneal edema, implant gets decentred or tilted, Day 7
Secondary Occurrence of undesirable events, Presence/absence of each event, including, but not limited to: inflammation, retinal detachment, macular edema, corneal endothelial lesion,corneal edema, implant gets decentred or tilted, Month 1
Secondary Occurrence of undesirable events, Presence/absence of each event, including, but not limited to: inflammation, retinal detachment, macular edema, corneal endothelial lesion,corneal edema, implant gets decentred or tilted, Month 7
See also
  Status Clinical Trial Phase
Completed NCT04685538 - Chloroprocaine 3% Gel Eye Drop as Topical Anestheticsin Phacoemulsification. Phase 3
Recruiting NCT06060041 - IC-8 Apthera IOL New Enrollment Post Approval Study
Recruiting NCT05518539 - Evaluation of Quality of Vision and Visual Outcomes With Bilateral Implantation of the Clareon PanOptix Intraocular Lens
Recruiting NCT05271942 - Tilt and Tumble vs Divide and Conquer - a Unique Comparison of the Two Cataract Surgery Methods N/A
Active, not recruiting NCT04778501 - PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Asia N/A
Completed NCT05062564 - Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye N/A
Completed NCT03751033 - Influence of DisCoVisc Ophthalmic Viscosurgical Device (OVD) on Intraoperative Aberrometry Readings N/A
Completed NCT02529488 - Investigation of AcrySof® IQ PanOptix™ Presbyopia-Correcting Intraocular Lens (IOL) Model TFNT00 N/A
Completed NCT04539548 - A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract Phase 3
Completed NCT03740659 - Evaluation Of Aqueous Humor Of Levofloxacin-Dexamethasone Eye Drops And Of Its Components In Patients Undergoing Cataract Surgery Phase 2
Completed NCT03494257 - Effect of Fixed Brinzolamide-brimonidine Combination on Intraocular Pressure After Phacoemulsification N/A
Completed NCT05119127 - Rotational Stability of Acrysof IQ Vivity Extended Vision Toric IOL and Refractive Visual Outcome. N/A
Active, not recruiting NCT04271709 - Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT) N/A
Recruiting NCT03713268 - Intraoperative OCT Guidance of Intraocular Surgery II
Completed NCT03739528 - Levo-Dexa vs. Tobra+Dexa for Prevention and Treatment of Inflammation and Prevention of Infection in Cataract Surgery Phase 3
Completed NCT02888210 - A Study Assessing Safety and Efficacy of MD-15 Intraocular Lens in Patients With Aphakic Eye After Cataract Surgery Phase 3
Completed NCT04332640 - Clinical Evaluation of the Next Generation Phaco System N/A
Recruiting NCT03638726 - Subconjunctival Atropine and Intracameral Epinephrine for Pupil Dilation in Phacoemulsification Phase 4
Completed NCT03050697 - Evaluation of the Safety and Performance of the HARMONI® Toric Lens N/A
Terminated NCT03145116 - Clinical Safety and Efficacy of CT ASPHINA 509 Lenses N/A